Pharmaceutical News Headlines for May 11 2012 ( Friday )

Posted by stockinvestips on 12:33 PM in , , | 0 comments

• Arena Pharmaceuticals, Inc. (ARNA) Obesity Pills Wins Over FDA Panel More...

• Cell Therapeutics, Inc. (CTIC)' Pixuvri® Approved in European Union as Monotherapy to Treat Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas More...

• Ampio Pharmaceuticals, Inc. (AMPE) Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion™ for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders More...

• FDA Voices Caution About Popular Bone Drugs, Including Novartis AG (NVS)'s Reclast More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Reports Top-line Results From GEMINI II Pivotal Phase 3 Trial More...

• Society for Cardiovascular Angiography and Interventions Release: Treatment with Ixmyelocel-T Shown to Improve Outcomes in Heart Failure Patients More...

• PolyMedix Inc. (PYMX.OB) Provides Update on PMX-60056 Program More...

• Wake-Up Call: Your Alarm Clock Could Be Making You Fat, University of Munich Study More...

• Pot Belly Boosts Risk of Sudden Cardiac Death, University of Minnesota Study More...

• Facebook, Twitter, Other Social Media are Brain Candy, Harvard University Study More...

• Maternal Antibodies to Gluten Linked to Schizophrenia Risk in Children, Karolinska Institute Study More...

• City of Hope Researchers Develop Potential Cure for Advanced Type 1 Diabetes in Laboratory More...

• National Institute for Clinical Excellence (NICE) Backs Allergan Inc. (AGN)'s Botox for Some Migraine Sufferers More...

• Mylan Inc. (MYL) Launches Generic Lipitor® in Five European Countries More...

• Pfizer Inc. (PFE) Employees Kiss Pensions Goodbye More...

• Rib-X Pharmaceuticals, Inc. Postpones IPO After Slashing Price by 50 Pct More...

• Oxford Finance Provides $27.5 Million Debt Financing Facility to Pacira Pharmaceuticals, Inc. More...

• Onconova Therapeutics Inc. Drug Developer Raises $7 Million in Financing More...

• AMAG Pharmaceuticals, Inc. (AMAG) Slumps as it Shelves Possible Sale More...

• Arena Pharmaceuticals, Inc. (ARNA) and Eisai Inc. (ESALF.PK) Expand Marketing and Supply Agreement for Lorcaserin More...

• Depomed, Inc. (DEPO) Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals More...

• China Biologic Products Names Chairman David Gao to Additional Post of CEO More...

• Myrexis, Inc. Appoints New Executive Management Team in Alignment With Strategic Initiatives, Taps New CEO More...

• Bionor Pharma ASA's Shareholders Voted Industry ExpertsSteen Kroyer, Jerry Zeldis and Benedicte Fossum to Its Board of Directors at Annual General Meeting More...

• Synthetic Biologics, Inc. (AEN) Appoints Jeffrey J. Krawsas Independent Chairman More...

• AmerisourceBergen Corporation (ABC) Names Tim G. Guttman Senior Vice President and Chief Financial Officer More...

• AVI BioPharma, Inc. (AVII) Announces First Quarter 2012 Financial Results and Recent Corporate Developments More...

• Alimera Sciences (ALIM) Reports First Quarter 2012 Financial Results More...

• Alexza Pharmaceuticals, Inc. (ALXA) Reports 2012 First Quarter Financial Results and Provides Business Update More...

• Aastrom Biosciences, Inc. (ASTM) Reports First Quarter 2012 Financial Results More...

• Amicus Therapeutics, Inc. (FOLD) Announces First Quarter 2012 Financial Results More...

• Amgen (AMGN) to Provide Testimony At FDA Stakeholder Hearing On Biosimilars More...

• Merck & Co., Inc. (MRK)'s Australia Win in Vioxx Ruling is Upheld by Court More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply

Newer Post Older Post Home